Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies.
about
JAK2V617F: Is It Sufficient as a Single Player in Splanchnic Venous Thrombosis?Are MPNs vascular diseases?Cerebral thrombosis and myeloproliferative neoplasms.In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban.Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anti-coagulant, protein S.
P2860
Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Platelet-mediated proteolytic ...... h haematological malignancies.
@ast
Platelet-mediated proteolytic ...... h haematological malignancies.
@en
type
label
Platelet-mediated proteolytic ...... h haematological malignancies.
@ast
Platelet-mediated proteolytic ...... h haematological malignancies.
@en
prefLabel
Platelet-mediated proteolytic ...... h haematological malignancies.
@ast
Platelet-mediated proteolytic ...... h haematological malignancies.
@en
P2093
P50
P356
P1476
Platelet-mediated proteolytic ...... th haematological malignancies
@en
P2093
Harry R Koene
Herm Jan M Brinkman
Ilze Dienava-Verdoold
Koen Mertens
Liane C J te Boome
P304
P356
10.1160/TH11-07-0457
P577
2012-02-08T00:00:00Z